Factor XIII: Difference between revisions
CSV import |
CSV import |
||
| Line 25: | Line 25: | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | {{No image}} | ||
== Factor_XIII == | |||
<gallery> | |||
File:Human_factor_XIII_1EVU.png|Human factor XIII | |||
</gallery> | |||
Revision as of 21:03, 23 February 2025
Factor XIII (also known as Fibrin Stabilizing Factor) is a protein that plays a crucial role in the blood clotting process. It is a transglutaminase enzyme, which means it catalyzes the formation of covalent bonds between proteins. This is particularly important in the final stages of the clotting process, where Factor XIII cross-links fibrin, stabilizing the clot.
Structure
Factor XIII is a tetramer composed of two A subunits and two B subunits. The A subunits carry the catalytic site of the enzyme, while the B subunits act as carrier molecules, protecting the A subunits from premature activation.
Function
The primary function of Factor XIII is to stabilize the fibrin clot that forms at the site of a wound. It does this by cross-linking the fibrin strands, making the clot more resistant to degradation. This is a crucial step in the clotting process, as it ensures that the clot remains in place long enough for the wound to heal.
Deficiency
Factor XIII deficiency is a rare genetic disorder characterized by abnormal blood clotting. This can lead to a variety of symptoms, including abnormal bleeding, poor wound healing, and in severe cases, life-threatening bleeding disorders.
Treatment
Treatment for Factor XIII deficiency typically involves regular infusions of Factor XIII concentrate. This can help to prevent bleeding episodes and improve wound healing.
